PESERICO, DENISE
 Distribuzione geografica
Continente #
NA - Nord America 420
EU - Europa 362
AS - Asia 146
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 933
Nazione #
US - Stati Uniti d'America 418
CN - Cina 94
IT - Italia 94
SE - Svezia 55
IE - Irlanda 45
GB - Regno Unito 44
FR - Francia 34
DE - Germania 28
RU - Federazione Russa 28
VN - Vietnam 24
FI - Finlandia 16
SG - Singapore 11
UA - Ucraina 7
JP - Giappone 5
KR - Corea 4
AU - Australia 2
CA - Canada 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EE - Estonia 2
LV - Lettonia 2
NL - Olanda 2
PK - Pakistan 2
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
EG - Egitto 1
HK - Hong Kong 1
IL - Israele 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
TR - Turchia 1
Totale 933
Città #
Chandler 135
Dublin 43
Southend 39
Redmond 25
Jacksonville 22
New York 22
Beijing 21
Woodbridge 21
Dong Ket 20
Verona 20
Ashburn 15
Lawrence 14
Princeton 14
Helsinki 12
Sindelfingen 10
Wilmington 10
Shenyang 9
Chions 8
Ann Arbor 7
Jinan 7
Nanjing 7
Singapore 7
Bussolengo 6
Haikou 6
Sant'Ambrogio di Valpolicella 6
Guangzhou 5
Hebei 5
Redwood City 5
Seattle 5
Cagliari 4
Seoul 4
Boardman 3
Esslingen am Neckar 3
Lancaster 3
Ningbo 3
Rome 3
San Giovanni Lupatoto 3
Bonndorf 2
Changsha 2
Dongguan 2
Fairfield 2
Hangzhou 2
Isola della Scala 2
Kobe 2
Lappeenranta 2
Mozzo 2
Rawalpindi 2
Riga 2
Roverbella 2
San Francisco 2
Shanghai 2
Taiyuan 2
Taizhou 2
Tallinn 2
Tokyo 2
Toronto 2
Zurich 2
Amsterdam 1
Brno 1
Cairo 1
Chicago 1
Civitanova Marche 1
Columbus 1
Dhaka 1
Eindhoven 1
Falkenstein 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Houston 1
Kemerovo 1
Kent 1
Lanzhou 1
Los Angeles 1
Lviv 1
Manila 1
Marino 1
Melbourne 1
Milan 1
Munich 1
Nagold 1
Prague 1
Riva 1
Riyadh 1
San Diego 1
San Martino di Lupari 1
Shenzhen 1
Sydney 1
Tel Aviv 1
Thiene 1
Vicenza 1
Vienna 1
Zhengzhou 1
Totale 628
Nome #
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 100
Active surveillance for early detection of SARS-CoV-2 infections across high-risk community key populations. 95
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 80
EZETIMIBE PREVENTS ISCHEMIA/REPERFUSION-INDUCED OXIDATIVE STRESS THROUGH UP-REGULATION OF NRF2/ARE AND UPR SIGNALING PATHWAYS AND INDUCTION OF AUTOPHAGY 77
Poster Session Abstracts 75
SARS-CoV-2 infection in health workers: analysis from Verona SIEROEPID Study during the pre-vaccination era 66
Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study 56
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 55
Correction to: Oxidative stress and Nrf2 expression in peripheral blood mononuclear cells derived from COPD patients: an observational longitudinal study 53
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study 47
Carbamazepine and Carbamazepine-10,11-epoxide measurement with the reference LC-MS/MS method and a routine immunoassay 47
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 47
Ezetimibe prevents ischemia/reperfusion-induced oxidative stress and up-regulates Nrf2/ARE and UPR signaling pathways 46
Plasma bile acid profile in patients with and without Type 2 Diabetes 46
EZETIMIBE PROTECTS THP-1 CELLS FROM ISCHEMIA-REPERFUSION INJURY REDUCING OXIDATIVE STRESS AND UP-REGULATING NRF2/ ARE GENE EXPRESSION 27
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments 18
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation 13
null 11
Plasma Bile Acid Profiling and Modulation of Secreted Mucin 5AC in Cholangiocarcinoma 10
Totale 969
Categoria #
all - tutte 3.987
article - articoli 2.929
book - libri 0
conference - conferenze 824
curatela - curatele 0
other - altro 234
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 3 3 3 7 1 3 20 10
2020/202179 1 14 3 9 9 9 0 0 0 4 6 24
2021/2022174 7 52 3 14 1 5 2 2 24 10 14 40
2022/2023368 21 44 28 61 22 73 3 22 67 3 16 8
2023/2024192 10 24 9 25 20 26 8 26 1 11 22 10
2024/202535 22 13 0 0 0 0 0 0 0 0 0 0
Totale 969